In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria.
The in vitro activity of teicoplanin and A16686, two new glycopeptide antibiotics was determined against 196 isolates of anaerobic bacteria. The activity of teicoplanin and A16686, in comparison with that of vancomycin, clindamycin, erythromycin and fusidic acid was 2 to 16 times higher against the gram positive anaerobes, namely, Propionibacterium acnes, Clostridium perfringens, Clostridium difficile, Clostridium species, Peptococcus species and Peptostreptococcus species. However, Bacteroides fragilis was resistant to teicoplanin and A16686 while Bacteroides melaninogenicus and Bacteroides bivius were found to be sensitive.
Hassan
H
H
Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur.
O'Hare
M D
MD
Felmingham
D
D
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001421:Bacteria, Anaerobic / Q000187:drug effects*; D002981:Clindamycin / Q000494:pharmacology; D047630:Depsipeptides; D004352:Drug Resistance, Microbial; D005672:Fusidic Acid / Q000494:pharmacology; D006020:Glycopeptides / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D010456:Peptides, Cyclic; D017334:Teicoplanin; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D047630:Depsipeptides; D006020:Glycopeptides; D010456:Peptides, Cyclic; C041438:ramoplanin; D002981:Clindamycin; D005672:Fusidic Acid; D017334:Teicoplanin; D014640:Vancomycin